Heart Failure Due to Reduced Ejection Fraction: Medical Management
WILLIAM E. CHAVEY, ROBERT V. HOGIKYAN, R. VAN HARRISON, JOHN M. NICKLAS
Angiotensin-converting enzyme inhibitors are the cornerstone of therapy for heart failure. Clinical trials have also demonstrated consistent mortality benefit from angiotensin receptor blockers, direct-acting vasodilators, beta blockers, and aldosterone antagonists. Recent...